Close Menu

NEW YORK – The GenomeWeb Index rose 3 percent in September, rebounding from a 4 percent loss in August and outperforming the broader markets, which were awash in volatility as they reacted to continued uncertainty in US presidential politics.

The index underperformed the Dow Jones Industrial Average, the Nasdaq, and the Nasdaq Biotechnology Index, which fell more than 2 percent, more than 5 percent, and a fraction of a percent, respectively. Individual stock performances in the GenomeWeb Index were positive in September, as 24 of the 37 stocks saw gains and 13 saw losses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.